
Childhood toxin is the ‘main explanation’ for spike in colon cancer among young people
The alarming rise in colorectal cancer among young people may have a stomach-churning culprit.
Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, suspects that exposure to a bacterial gut toxin during childhood could set the stage for disease decades later.
In a recent appearance before the British Parliament, he called the theory “probably the leading explanation at the moment” for the sea change in the demographics of patients with a disease historically associated with the elderly.
His comments follow the publication last year of a groundbreaking study examining colibactin, a toxin produced by certain strains of E. coli. coli that colonize the colon and rectum.
Researchers have found that childhood exposure to the bacteria leaves a distinct genetic imprint in cells in the colon. These mutations were 3.3 times more common in patients with early-onset cases than in those diagnosed after age 70.
Even more worrying, mutations linked to colibactin appeared in the early stages of tumor development, often during the first 10 years of life.
The study also found that about 15% of APC driver mutations – among the earliest genetic changes that directly fuel cancer growth – were linked to colibactin.
“If someone acquires one of these mutations before the age of 10, they could have a decades head start on developing colorectal cancer, getting it at 40 instead of 60,” Dr. Ludmil Alexandrov, lead author of the study and professor at the University of California, San Diego, previously told the Post.
Established risk factors for colorectal cancer include obesity, smoking and alcohol consumption. But Smith-Byrne said those cases represent only about half of the cases diagnosed by doctors.
Testifying before the House of Commons science and technology committee, he said it was not “plausible” that these factors alone could explain the rise in early cases, according to the Guardian.
It’s not clear how colibactin may contribute to the development of cancer, but researchers are working to better understand this link.
“If it causes mutations, it causes mutations at a sensitive time earlier in life, and that can give that person’s colon or rectum a head start in their path to cancer or the development of these tumors,” Smith-Byrne said, according to the outlet.
Colibactin appears to be largely associated with people born after 1960, which could provide a clue to the increase in cases among younger generations.
“Something happened in the E coli bacteria… There must have been a mutation, and there is a new bacteria,” Professor Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee, according to the Guardian.
And people may have no idea they’re being exposed.
Alexandrov told the Post last year that colibactin is spread “by E. coli colonization — usually through the gut, and often without any obvious symptoms.”
Professor Elio Riboli, a cancer epidemiologist at Imperial College London, said colibactin is mainly found in people born after 1960.
“Something happened in the E.coli bacteria… There must have been a mutation, and there is a new bacteria,” he told the committee, according to the Guardian.
Alexandrov’s study also revealed distinct patterns of mutations in colorectal cancer cases from countries including Argentina, Brazil, Colombia, Russia and Thailand, suggesting that local environmental exposures may influence cancer risk.
The findings could eventually pave the way for more targeted prevention strategies tailored to specific regions, the researchers said.
The stakes are high. Rates of colorectal cancer are increasing among young people in at least 27 countries, including the United States, where nearly one in five diagnoses now occurs in young adults.
In January, the disease became the leading cause of cancer deaths among Americans under 50. Mortality rates in this age group have increased by 1% per year since 2005.
Gn Health